20/20 Biolabs, Inc. (AIDX) Ownership
AIDX ownership summary
as of October 18, 2026- Institutions
- 4.2% of shares outstanding
- Insiders
- 20.40% of shares outstanding
- Shares outstanding
- 12.8M
- Float
- 10.8M shares available to trade
- Short interest
- 0.42% 45K shares short
- Days to cover
- 0.81 short interest down 3.5% vs prior month
- Institutions 4.23%
- Insiders 20.40%
- Other investors 75.37%
AIDX top institutional holders
17 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Cresset Asset Management, LLC | 1.96% | 240K | $62,432 | −24,246 (−9.2%) | June 30, 2026 |
| 2 | HRT FINANCIAL LLC | 0.73% | 89K | $23,211 | +89,273 (0.0%) | June 30, 2026 |
| 3 | Vanguard Fiduciary Trust Co | 0.43% | 52K | $13,543 | +52,087 (0.0%) | June 30, 2026 |
| 4 | Geode Capital Management, LLC | 0.40% | 49K | $12,777 | +49,141 (0.0%) | June 30, 2026 |
| 5 | Atlantic Union Bankshares Corp | 0.29% | 35K | $9,126 | +35,099 (0.0%) | June 30, 2026 |
| 6 | Vanguard Capital Management, LLC | 0.20% | 25K | $6,378 | +24,530 (0.0%) | June 30, 2026 |
| 7 | Citadel Advisors Llc | 0.19% | 23K | $6,033 | +6,978 (+43.0%) | June 30, 2026 |
| 8 | Bank of America Corp | 0.11% | 13K | $3,386 | +13,024 (0.0%) | June 30, 2026 |
| 9 | Susquehanna International Group, LLP | 0.08% | 10K | $2,604 | +10,014 (0.0%) | June 30, 2026 |
| 10 | McDonald Partners, LLC | 0.02% | 2,800 | $728 | +2,800 (0.0%) | June 30, 2026 |
| 11 | SignatureFD, LLC | 0.01% | 767 | $199 | +767 (0.0%) | June 30, 2026 |
| 12 | Morgan Stanley - Brokerage Accounts | <0.01% | 283 | $74 | +283 (0.0%) | June 30, 2026 |
| 13 | Hanson Mcclain Inc | <0.01% | 172 | $45 | +142 (+473.3%) | June 30, 2026 |
| 14 | Toth Financial Advisory Corp | <0.01% | 100 | $26 | −57 (−36.3%) | June 30, 2026 |
| 15 | UBS Group AG | 0.00% | 3 | $1 | −8,311 (−100.0%) | June 30, 2026 |
| 16 | Mccormack Advisors International | 0.00% | — | — | −1,000 (−100.0%) | June 30, 2026 |
| 17 | XTX Topco Ltd | 0.00% | — | — | −10,329 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 17, 12 holders added 284K shares and 5 cut 44K.
AIDX top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.36% | 44K | $11,333 | −234 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Nasdaq Composite Index | 0.04% | 5,319 | $1,383 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
AIDX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns AIDX
Institutional investors own 4.2% of 20/20 Biolabs's shares and insiders 20.40%. The largest holder is Cresset Asset Management, LLC with 1.96% of the shares (240K), as of June 30, 2026. Among the top 17 institutions, 12 added shares and 5 reduced their stake in the latest filings. Short interest is 0.42% of the float, or 0.81 days of average trading volume. The share count rose 119.0% since 2023.
Related: AIDX analyst forecast, AIDX key metrics. See the AIDX stock overview for the latest quote and news.
AIDX ownership FAQ
Who owns the most 20/20 Biolabs stock?
The largest shareholders of 20/20 Biolabs are Cresset Asset Management, LLC (1.96%), HRT FINANCIAL LLC (0.73%), Vanguard Fiduciary Trust Co (0.43%), Geode Capital Management, LLC (0.40%), Atlantic Union Bankshares Corp (0.29%).
What percentage of 20/20 Biolabs is owned by institutions?
Institutions hold 4.2% of 20/20 Biolabs's shares outstanding; insiders hold 20.40%.
Which funds own 20/20 Biolabs?
The largest fund holders of 20/20 Biolabs are Fidelity Extended Market Index (0.36%), Fidelity Nasdaq Composite Index (0.04%).
What is 20/20 Biolabs's short interest?
45K shares of 20/20 Biolabs were sold short, 0.42% of the float; at the average daily volume it would take 0.81 days to cover.
How many shares of 20/20 Biolabs are outstanding?
20/20 Biolabs has 12.8M shares outstanding, of which 10.8M are in the public float.